Practical Protein Chemistry - A. Darbre 1989
Micro-scale amino acid sequence analysis using a gas-phase peptide-protein sequencer
Discussion
Amount of sample analyzed
A representative list of the investigated samples is given in Table 17.3. Currently, the minimum amount of material required to obtain useful sequence information is 5–10 pmol (0.05–0.1 µg) for a medium-sized protein and 50 pmol (0.05 µg) for a short peptide. Sequencing heavily glycosylated Proteins, such as Erythropoietin (60% CARBOHYDRATES), has not posed any particular problems so far, although it is necessary to increase the Cleavage time for Amino Acids located both before and after the glycosylated residue in order to minimize residual amino acid levels caused by incomplete Cleavage of the preceding ones. A similar approach is taken for sequences containing Proline followed by amino acid residues with bulky side chains (Lys, Arg, Leu in Aplysia neuropeptide B).
Perhaps the most important advantage of the gas-phase Sequencer is that it makes it possible to analyze trace amounts of Polypeptides isolated by Polyacrylamide gel Electrophoresis in the presence of SDS and eluted from stained gels (melanoma Cell surface antigen, membrane phosphoprotein from Aplysia, interleukin II, or T-cell growth factor).
Class="center">Table 17.3. Peptides analyzed using the gas-phase sequencer
|
Ratio of identified residues to total residues |
Amount |
||
|
Analyzed sample |
pmol |
µg |
|
|
Angiotensin |
8/8 |
500 |
0.5 |
|
Angiotensin |
6/8 |
50 |
0.05 |
|
14/14 |
1400 |
2.0 |
|
|
Insulin B-chain |
30/30 |
300 |
1.0 |
|
Aplysia neuropeptide B |
31/34 |
500 |
2.0 |
|
Dynorphin |
14/17 |
20 |
0.04 |
|
90/153 |
10 000 |
165 |
|
|
Myoglobin |
22/153 |
5 |
0.08 |
|
Drosophila larval cuticle protein 1a |
55/166 |
850 |
15 |
|
Drosophila larval cuticle protein 3a |
36/96 |
900 |
9 |
|
Membrane phosphoprotein (M 22∙103) from Aplysia b |
23/200 |
15 |
0.3 |
|
Human T-cell growth factor b |
15/160 |
25 |
1.0 |
|
Human histocompatibility antigen HLA-DR α-chain |
49/300 |
700 |
23 |
|
Human histocompatibility antigen HLA-DR β-chain |
39/240 |
500 |
13 |
|
Human erythropoietin c |
28/150 |
100 |
1.6 |
|
Human melanoma cell surface antigen c |
13/850 |
60 |
5.5 |
a Purified by isoelectric focusing in a urea-containing PAGE gel. Electrophoretically eluted from an SDS-PAGE gel stained with Coomassie Brilliant Blue. c 60% carbohydrate by weight.
Last update: 06/08/2026
Editorial and Educational Adaptation: This material has been compiled based on the primary/original source text. The project team performed an editorial review, corrected technical inaccuracies, structured sections, and adapted the content for an educational format.
What was processed:
- elimination of formatting defects (OCR errors, structural breaks, corrupted characters);
- editorial organization of content;
- standardization of terminology in accordance with academic sources;
- verification of factual statements against the original source text.
All mentions of the author, publication year, and origin of the primary text have been preserved in accordance with the source.